Information
- News Release
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
- Information
Elix will exhibit a booth and participate in partnering at “BioJapan 2025” held at Pacifico Yokohama from October 8 to 10
- Information
Elix CEO Shinya’s Interview Was Published in IT Business Today
- Information
Article on the Provision of Elix Discovery™ to KYORIN Pharmaceutical Featured in TechDay – CFOTech Asia
- Information
Article on the Provision of Elix Discovery™ to KYORIN Pharmaceutical Featured in The Pharma Letter
- Information
Article on the Provision of Elix Discovery™ to KYORIN Pharmaceutical Featured in BioPharmaTrend and AI BRIEF
- News Release
Elix Provides AI Drug Discovery Platform “Elix Discovery™” to KYORIN Pharmaceutical
- Information
Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in Base to Base Biotech Podcast
- Information
Our Operating Officer & CSO, Tasuku Ishida, to Deliver an Invited Lecture at 3rd Targeted Protein Degradation Conference in Japan